The editors of the Methodist DeBakey Cardiovascular Journal thank Miguel Valderrábano, MD, for his leadership as guest editor of this issue on cardiac electrophysiology, an update to the electrophysiology issue he spearheaded for this publication in 2015.

Dr. Valderrábano is the Lois and Carl Davis Centennial Chair and chief of cardiac electrophysiology at the Houston Methodist DeBakey Heart & Vascular Center and professor of cardiology at the Houston Methodist Academic Institute. He also leads a basic research laboratory focused on finding new and more effective treatments for atrial fibrillation, including epicardial mapping and ablation. His research team uses optical mapping techniques in cell cultures and other models to explore mechanisms of ventricular fibrillation and sudden cardiac death.

The Valderrábano Lab has received grant funding from the American Heart Association and the National Institutes of Health (NIH), including an NIH-funded study evaluating the efficacy and safety of an alcohol infusion treatment for patients with persistent atrial fibrillation.

Dr. Valderrábano earned his medical degree from the Universidad Autónoma De Madrid in Madrid, Spain, then went on to complete his internal medicine training at the UCLA-West Los Angeles VA Medical Center in California. From there, he completed fellowships in cardiology and clinical cardiac electrophysiology at Cedars-Sinai Medical Center in Los Angeles, where he was named chief cardiology fellow in 2002. His first faculty position was at the David Geffen School of Medicine at UCLA, where he was named director of the Implanted Devices Clinic at UCLA’s Cardiac Arrhythmia Center and assistant professor of medicine at UCLA Medical Center. Dr. Valderrábano holds memberships in the American Heart Association, American College of Cardiology, and the Heart Rhythm Society.

Figure 1. 

Miguel Valderrábano, MD